A detailed history of Joel Isaacson & Co., LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Joel Isaacson & Co., LLC holds 4,830 shares of LLY stock, worth $3.84 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
4,830
Previous 5,240 7.82%
Holding current value
$3.84 Million
Previous $4.74 Million 9.8%
% of portfolio
0.21%
Previous 0.25%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$772.14 - $960.02 $316,577 - $393,608
-410 Reduced 7.82%
4,830 $4.28 Million
Q2 2024

Jul 23, 2024

SELL
$724.87 - $909.04 $65,238 - $81,813
-90 Reduced 1.69%
5,240 $4.74 Million
Q1 2024

Apr 29, 2024

BUY
$592.2 - $792.28 $194,241 - $259,867
328 Added 6.56%
5,330 $4.15 Million
Q4 2023

Jan 24, 2024

BUY
$525.19 - $619.13 $15,230 - $17,954
29 Added 0.58%
5,002 $2.92 Million
Q3 2023

Oct 23, 2023

BUY
$434.7 - $599.3 $55,206 - $76,111
127 Added 2.62%
4,973 $2.67 Million
Q2 2023

Jul 26, 2023

BUY
$350.74 - $468.98 $37,879 - $50,649
108 Added 2.28%
4,846 $2.27 Million
Q1 2023

Apr 24, 2023

SELL
$310.63 - $364.82 $24,850 - $29,185
-80 Reduced 1.66%
4,738 $1.63 Million
Q4 2022

Jan 27, 2023

BUY
$321.55 - $374.67 $36,656 - $42,712
114 Added 2.42%
4,818 $0
Q3 2022

Oct 13, 2022

SELL
$296.48 - $337.87 $358,444 - $408,484
-1,209 Reduced 20.45%
4,704 $1.52 Million
Q2 2022

Jul 15, 2022

BUY
$278.73 - $327.27 $5,295 - $6,218
19 Added 0.32%
5,913 $1.92 Million
Q4 2021

Jan 19, 2022

BUY
$224.85 - $279.04 $78,697 - $97,664
350 Added 6.31%
5,894 $1.63 Million
Q3 2021

Oct 21, 2021

BUY
$221.6 - $272.71 $165,978 - $204,259
749 Added 15.62%
5,544 $1.28 Million
Q2 2021

Jul 20, 2021

BUY
$180.55 - $233.54 $9,749 - $12,611
54 Added 1.14%
4,795 $1.1 Million
Q1 2021

Apr 23, 2021

BUY
$164.32 - $212.72 $44,859 - $58,072
273 Added 6.11%
4,741 $886,000
Q4 2020

Jan 22, 2021

SELL
$130.46 - $172.63 $27,787 - $36,770
-213 Reduced 4.55%
4,468 $754,000
Q3 2020

Oct 14, 2020

BUY
$146.22 - $169.13 $1,900 - $2,198
13 Added 0.28%
4,681 $693,000
Q2 2020

Jul 21, 2020

BUY
$136.42 - $164.18 $13,641 - $16,418
100 Added 2.19%
4,668 $766,000
Q1 2020

Apr 21, 2020

SELL
$119.05 - $147.35 $131,669 - $162,969
-1,106 Reduced 19.49%
4,568 $634,000
Q3 2019

Oct 15, 2019

SELL
$106.79 - $116.16 $69,840 - $75,968
-654 Reduced 10.34%
5,674 $635,000
Q2 2019

Jul 11, 2019

SELL
$110.79 - $129.32 $542,317 - $633,021
-4,895 Reduced 43.62%
6,328 $701,000
Q1 2019

Apr 09, 2019

BUY
$111.31 - $131.02 $80,254 - $94,465
721 Added 6.87%
11,223 $1.46 Million
Q4 2018

Jan 18, 2019

BUY
$105.9 - $118.64 $761,209 - $852,784
7,188 Added 216.9%
10,502 $1.22 Million
Q3 2017

Nov 02, 2017

BUY
$77.07 - $85.54 $255,409 - $283,479
3,314
3,314 $283,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Joel Isaacson & Co., LLC Portfolio

Follow Joel Isaacson & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Joel Isaacson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Joel Isaacson & Co., LLC with notifications on news.